yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologiká - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.
axhidrox
dr. august wolff gmbh & co. kg arzneimittel, nemecko - glykopyrónium - 46 - dermatologica
vitaros 3 mg/g krém
recordati ireland limited, Írsko - alprostadil - 83 - vasodilatantia
vitaros 2 mg/g krém
recordati ireland limited, Írsko - alprostadil - 83 - vasodilatantia
soolantra 10 mg/g krém
galderma international, francúzsko - ivermektín - 46 - dermatologica
recreol 50 mg/g krém
as grindeks, lotyšsko - dexpantenol - 46 - dermatologica
romla 25 mg/g + 25 mg/g krém
magnapharm sk, slovensko - amidy, kombinácie - 01 - anaesthetica (lokÁlne)
eczoria 0,5 mg/g
exeltis slovakia s.r.o. - klobetazol - 46 - dermatologica
prutica 0,5 mg/g krém
exeltis slovakia s.r.o. - flutikazón - 46 - dermatologica
beriate 250 iu
csl behring gmbh, nemecko - koagulačný faktor viii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)